Source:http://linkedlifedata.com/resource/pubmed/id/16025148
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2005-8-19
|
pubmed:abstractText |
Hypermethylation of CpG islands is a phenomenon commonly observed during the development and progression of human tumors. Detection of methylated-CpG islands in easily accessible biological materials such as serum has the potential to be useful for the early diagnosis of cancer. Most currently used methods for detecting methylated-CpG islands are based on sodium bisulfite conversion of genomic DNA, followed by PCR reactions. Here we describe a method, methylated-CpG island recovery assay (MIRA) that does not depend on the use of sodium bisulfite but has similar sensitivity and specificity as bisulfite-based approaches. Methyl-CpG-binding domain proteins, such as methyl-CpG-binding domain protein-2 (MBD2), have the capacity to bind specifically to methylated DNA sequences. In the MIRA procedure, sonicated genomic DNA isolated from cells or tissue is incubated with a matrix containing glutathione-S-transferase-MBD2b in the presence of methyl-CpG-binding domain protein 3-like-1, a binding partner of MBD2 that increases the affinity of MBD2 for methylated DNA. Specifically bound DNA is eluted from the matrix and gene-specific PCR reactions are performed to detect CpG island methylation. Methylation can be detected using 1 ng of DNA or 3000 cells. MIRA is a specific and sensitive, but not laborious, technique that can be clinically useful in the detection and diagnosis of any DNA methylation-associated disease, including cancer.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0023-6837
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1172-80
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16025148-Base Sequence,
pubmed-meshheading:16025148-CpG Islands,
pubmed-meshheading:16025148-DNA,
pubmed-meshheading:16025148-DNA Methylation,
pubmed-meshheading:16025148-Humans,
pubmed-meshheading:16025148-Molecular Sequence Data,
pubmed-meshheading:16025148-Neoplasms,
pubmed-meshheading:16025148-Plasmids,
pubmed-meshheading:16025148-Polymerase Chain Reaction,
pubmed-meshheading:16025148-Promoter Regions, Genetic,
pubmed-meshheading:16025148-Sensitivity and Specificity
|
pubmed:year |
2005
|
pubmed:articleTitle |
Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer.
|
pubmed:affiliation |
Division of Biology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|